TTFLOther Textile Products
Trident Texofab Ltd — Profit & Loss Statement
₹45.82
+0.00%
Trident Texofab Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.02 Cr | -0.03 Cr | 76247.68 | — |
| Tax Rate For Calcs | 0.03 | 0.08 | 0.19 | 0.23 | — |
| Normalized EBITDA | 8.77 Cr | 6.54 Cr | 10.07 Cr | 6.70 Cr | — |
| Total Unusual Items | 0.00 | 0.31 Cr | -0.14 Cr | 0.03 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.31 Cr | -0.14 Cr | 0.03 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 2.51 Cr | 1.08 Cr | 2.22 Cr | 0.98 Cr | — |
| Reconciled Depreciation | 1.65 Cr | 1.65 Cr | 1.64 Cr | 1.47 Cr | — |
| Reconciled Cost Of Revenue | 105.82 Cr | 83.83 Cr | 81.58 Cr | 72.65 Cr | — |
| EBITDA | 8.77 Cr | 6.85 Cr | 9.93 Cr | 6.74 Cr | — |
| EBIT | 7.13 Cr | 5.21 Cr | 8.29 Cr | 5.27 Cr | — |
| Net Interest Income | -4.55 Cr | -4.04 Cr | -3.92 Cr | -3.73 Cr | — |
| Interest Expense | 4.55 Cr | 4.04 Cr | 5.56 Cr | 4.00 Cr | — |
| Normalized Income | 2.51 Cr | 0.79 Cr | 2.33 Cr | 0.96 Cr | — |
| Net Income From Continuing And Discontinued Operation | 2.51 Cr | 1.08 Cr | 2.22 Cr | 0.98 Cr | — |
| Total Expenses | 118.23 Cr | 94.98 Cr | 89.78 Cr | 79.75 Cr | — |
| Diluted NI Availto Com Stockholders | 2.51 Cr | 1.08 Cr | 2.22 Cr | 0.98 Cr | — |
| Net Income Common Stockholders | 2.51 Cr | 1.08 Cr | 2.22 Cr | 0.98 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 2.51 Cr | 1.08 Cr | 2.22 Cr | 0.98 Cr | — |
| Net Income Including Noncontrolling Interests | 2.51 Cr | 1.08 Cr | 2.22 Cr | 0.98 Cr | — |
| Net Income Discontinuous Operations | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Continuous Operations | 2.51 Cr | 1.08 Cr | 2.22 Cr | 0.98 Cr | — |
| Tax Provision | 0.07 Cr | 0.09 Cr | 0.51 Cr | 0.29 Cr | — |
| Pretax Income | 2.58 Cr | 1.17 Cr | 2.73 Cr | 1.27 Cr | — |
| Other Non Operating Income Expenses | 3.30 Cr | 0.39 Cr | 0.21 Cr | 0.41 Cr | — |
| Special Income Charges | 0.00 | 0.31 Cr | -0.14 Cr | 0.03 Cr | — |
| Net Non Operating Interest Income Expense | -4.55 Cr | -4.04 Cr | -3.92 Cr | -3.73 Cr | — |
| Interest Expense Non Operating | 4.55 Cr | 4.04 Cr | 5.56 Cr | 4.00 Cr | — |
| Operating Income | 3.82 Cr | 4.51 Cr | 6.57 Cr | 4.55 Cr | — |
| Operating Expense | 12.41 Cr | 11.15 Cr | 8.20 Cr | 7.10 Cr | — |
| Other Operating Expenses | 7.90 Cr | 6.80 Cr | 3.25 Cr | 2.71 Cr | — |
| Depreciation And Amortization In Income Statement | 1.65 Cr | 1.65 Cr | 1.64 Cr | 1.47 Cr | — |
| Depreciation Income Statement | 1.65 Cr | 1.65 Cr | 1.64 Cr | 1.47 Cr | — |
| Gross Profit | 16.23 Cr | 15.65 Cr | 14.78 Cr | 11.65 Cr | — |
| Cost Of Revenue | 105.82 Cr | 83.83 Cr | 81.58 Cr | 72.65 Cr | — |
| Total Revenue | 122.06 Cr | 99.48 Cr | 96.36 Cr | 84.29 Cr | — |
| Operating Revenue | 122.06 Cr | 99.48 Cr | 96.36 Cr | 84.29 Cr | — |
| Interest Income | — | 0.24 Cr | 1.70 Cr | 0.31 Cr | 1.55 Cr |
| Rent Expense Supplemental | — | 17000.00 | 20000.00 | 0.05 Cr | 0.09 Cr |
| Diluted Average Shares | — | 1.01 Cr | 1.01 Cr | 1.01 Cr | 1.00 Cr |
| Basic Average Shares | — | 1.01 Cr | 1.01 Cr | 1.01 Cr | 1.00 Cr |
| Diluted EPS | — | 1.07 | 2.20 | 0.98 | 0.35 |
| Basic EPS | — | 1.07 | 2.20 | 0.98 | 0.35 |
| Average Dilution Earnings | — | 0.00 | 0.00 | — | — |
| Other Special Charges | — | -0.31 Cr | 0.13 Cr | -0.05 Cr | -0.05 Cr |
| Write Off | — | -0.36 Cr | 72000.00 | 0.02 Cr | 0.00 |
| Total Other Finance Cost | — | 0.06 Cr | 0.05 Cr | 0.04 Cr | 0.07 Cr |
| Interest Income Non Operating | — | 0.24 Cr | 1.70 Cr | 0.31 Cr | 1.55 Cr |
| Research And Development | — | 27000.00 | 38000.00 | 35000.00 | 21000.00 |
| Selling General And Administration | — | 0.52 Cr | 0.52 Cr | 0.45 Cr | 0.42 Cr |
| Selling And Marketing Expense | — | 0.13 Cr | 0.18 Cr | 0.09 Cr | 0.08 Cr |
| General And Administrative Expense | — | 0.39 Cr | 0.33 Cr | 0.37 Cr | 0.34 Cr |
| Rent And Landing Fees | — | 17000.00 | 20000.00 | 0.05 Cr | 0.09 Cr |
| Preferred Stock Dividends | — | — | 0.00 | 0.00 | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Trident Texofab Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.